AUG 18, 2026 · PHASE 2/3 TRIAL
Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion
ClinicalTrials.gov
This is a Phase 2/3 trial registration with no posted results; the study is not yet recruiting and outcome data are unavailable, making it an early-stage intervention feasibility record rather than evidence of efficacy.
Reported
Estimated sample size35
Study phasePhase 2, Phase 3
Primary outcome measure 1Patient Health Questionnaire 9 (PHQ-9) depr…